Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abdulgabar Salama. (2017) Emerging drugs for immune thrombocytopenia (ITP). Expert Opinion on Emerging Drugs 22:1, pages 27-38.
Read now
Read now
Zeping Zhou, Zhuoqing Qiao, Huiyuan Li, Na Luo, Xian Zhang, Feng Xue & Renchi Yang. (2016) Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases. Autoimmunity 49:1, pages 50-57.
Read now
Read now
Articles from other publishers (7)
Huimin Du, Jiamin Wang, Joel Livingston, Ziyad Alrajhi, Melanie Kirby‐Allen, Brian Chan, Rebecca Hancock‐Howard & Peter C. Coyte. (2023) A cost–utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first‐line therapies. Pediatric Blood & Cancer 70:9.
Crossref
Crossref
Na Li, Syed Mahamad, Sameer Parpia, Alfonso Iorio, Farid Foroutan, Nancy M. Heddle, Cyrus C. Hsia, Michelle Sholzberg, Emily Rimmer, Sudeep Shivakumar, Haowei (Linda) Sun, Mohammad Refaei, Caroline Hamm & Donald M. Arnold. (2022) Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis 20:12, pages 2988-2997.
Crossref
Crossref
Jasjit Kaur Rooprai & Karima Khamisa. (2018) Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases. Case Reports in Hematology 2018, pages 1-6.
Crossref
Crossref
Junji Lin, Xinke Zhang, Xiaoyan Li, David Chandler, Ivy Altomare, Jeffrey S. Wasser & Karynsa Cetin. (2017) Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States. Clinical Therapeutics 39:3, pages 603-609.e1.
Crossref
Crossref
Anton Neschadim, Lakshmi P. Kotra & Donald R. Branch. (2016) Small molecule phagocytosis inhibitors for immune cytopenias. Autoimmunity Reviews 15:8, pages 843-847.
Crossref
Crossref
Jacqueline Kerr, Isabella Quinti, Martha Eibl, Helen Chapel, Peter J. Späth, W. A. Carrock Sewell, Abdulgabar Salama, Ivo N. van Schaik, Taco W. Kuijpers & Hans-Hartmut Peter. (2014) Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe. Frontiers in Immunology 5.
Crossref
Crossref
Dawn Lee, Patrick Thornton, Alexander Hirst, Lucie Kutikova, Robert Deuson & Nic Brereton. (2013) Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland. Applied Health Economics and Health Policy 11:5, pages 457-469.
Crossref
Crossref